Uj. Woermann et al., INCREASED BONE METABOLISM IN A PATIENT UNDERGOING LONG-TERM RHG-CSF TREATMENT FOR IDIOPATHIC ACQUIRED NEUTROPENIA, Annals of hematology, 66(5), 1993, pp. 267-268
Recombinant human granulocyte colony-stimulating factor (rhG-CSF) has
been used mainly for treatment of chemotherapy-induced neutropenia. Th
e reported side effects were of minor importance. We describe a case o
f long-term treatment with rhG-CSF, in which we observed enhanced bone
remodeling.